Clinical and genetic study of developmental and epileptic encephalopathy in Argentinean pediatric patients.

Autor:	Juanes M; Unidad de Genómica, Hospital de Pediatría Juan P. Garrahan, Buenos Aires, Argentina. E-mail: matiasjuanes@hotmail.com., Loos M; Servicio de Neurología, Hospital de Pediatría Juan P. Garrahan, Buenos Aires, Argentina., Reyes G; Servicio de Neurología, Hospital de Pediatría Juan P. Garrahan, Buenos Aires, Argentina., Veneruzzo G; Unidad de Genómica, Hospital de Pediatría Juan P. Garrahan, Buenos Aires, Argentina., García FM; Unidad de Genómica, Hospital de Pediatría Juan P. Garrahan, Buenos Aires, Argentina., Aschettino G; Unidad de Genómica, Hospital de Pediatría Juan P. Garrahan, Buenos Aires, Argentina., Calligaris S; Servicio de Neurología, Hospital de Pediatría Juan P. Garrahan, Buenos Aires, Argentina., Martín ME; Unidad de Genómica, Hospital de Pediatría Juan P. Garrahan, Buenos Aires, Argentina., Foncuberta ME; Unidad de Genómica, Hospital de Pediatría Juan P. Garrahan, Buenos Aires, Argentina.; Laboratorio de Biología Molecular-Genética, Hospital de Pediatría Juan P. Garrahan, Buenos Aires, Argentina., Alonso CN; Unidad de Genómica, Hospital de Pediatría Juan P. Garrahan, Buenos Aires, Argentina., Caraballo RH; Servicio de Neurología, Hospital de Pediatría Juan P. Garrahan, Buenos Aires, Argentina.
Jazyk:	angličtina
Zdroj:	Medicina [Medicina (B Aires)] 2022; Vol. 82 (6), pp. 856-865.
Abstrakt:	Introduction: The aim of this study was to extend our knowledge of the genetic background of Argentinean pediatric patients with developmental and epileptic encephalopathy (DEE) applying a next generation sequencing (NGS) panel. Methods: Thirty one patients with DEE were studied, including these phenotypes: Dravet syndrome (n:7), Dravet like syndrome (n:3), West syndrome (WS) (n:6), WS that evolved to Lennox-Gastaut syndrome (LGS) (n:4), epilepsy of infancy with migrating focal seizures (n:2), continuous spikes and waves during slow sleep evolving to LGS (n:1), LGS (n:1), myoclonic status in non-progressive encephalopathy (n:1), myoclonic atonic epilepsy (n:1), epileptic encephalopathy with multifocal spikes (n:1) and unclassified epileptic encephalopathy (n:4). Fifty-two genes frequently associated with DEE were studied by NGS in genomic DNA from peripheral blood. Results: Relevant variants were detected in 12 cases; 6 novel pathogenic or likely pathogenic variants, 6 previously reported as pathogenic and 1 variant of unknown significance. Single-nucleotide heterozygous variants were identified in the SCN1A (5), GABRG2 (1), STXBP1 (2) genes, a mosaic variant in SCN2A (1) and a homozygous variant in SCN1B (1). Additionally, a heterozygous deletion involving the SCN1A, SCN2A and SCN3A genes (1), and the most frequent triplet repeat expansion in the ARX gene (1) were detected. Discussion: Genetic diagnosis was made in 39% of patients. We emphasize the importance of considering mosaic variants, copy number variants and hereditary forms when designing and interpreting molecular studies, to optimize diagnosis and management of patients. Approximately 42% of the detected variants were novel, expanding the knowledge of the molecular basis of DEEs in Latin-American patients.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu